Table 1.
Pre-Infection data and post-COVID symptoms of the total sample.
| Total Sample (n = 293) | |
|---|---|
| Age, mean (SD), years | 56.5 (13.0) |
| Gender, female n (%) | 145 (49.5%) |
| Weight, mean (SD), kg. | 80.8 (17.0) |
| Height, mean (SD), cm. | 168 (8.5) |
| Number co-morbidities, mean (SD) | 1.3 (1.0) |
| Medical co-morbidities, n (%) | |
| Hypertension | 103 (35.1%) |
| Diabetes | 31 (10.6%) |
| Cardiovascular Diseases | 21 (7.1%) |
| Asthma | 32 (10.9%) |
| Obesity | 90 (30.7%) |
| Chronic Obstructive Pulmonary Disease | 6 (2.0%) |
| Number post-COVID symptoms, mean (SD) | 3.0 (1.9) |
| Post-COVID symptoms, n (%) | |
| Fatigue | 184 (62.8%) |
| Pain Symptoms | 117 (39.9%) |
| Memory Loss | 94 (32.1%) |
| Hair Loss | 78 (26.6%) |
| Concentration Loss | 44 (15.0%) |
| Cognitive Blunting-Brain Fog | 42 (14.3%) |
| Dyspnoea | 41 (14.0%) |
| Ocular Disorders | 41(14.0%) |
| Skin Rashes | 37 (12.6%) |
| Anosmia/Hyposmia | 30 (10.2%) |
| Gastrointestinal Disorders | 27 (9.2%) |
| Ageusia/Hypogeusia | 21 (7.6%) |
| Days at hospital, mean (SD) | 8.2 (7.9) |